Ragistomig is a 4-1BB X PD-L1 bispecific antibody, designed to treat patients with advanced or metastatic solid tumors, ...

NANTES, France, December 8th, 2025 - 7:30am CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) today announced an amendment to its partnership agreement with AbbVie regarding ABBV-230, a ...

(Nasdaq: BIIB) – today announced that The Journal of the American Medical Association (JAMA) Neurology has published final results from the completed Phase 3 VALOR study and its open-label extension ...

GLP-1 medications like semaglutide in Ozempic and Wegovy help people lose weight. But they need to be taken for years, ...

The application is based on the successful outcome of the pivotal US Phase 3 ConfIdeS trial in highly sensitized patientsImlifidase is an enzyme that rapidly and efficiently cleaves all types of ...

Complementary strategic combination to expand Citizens Business Bank’s presence in the Bay Area and to enhance ...

Electro Optic Systems shares are sharply higher after the company announced a lucrative contract with a South Korean customer ...

CI Financial Corp. ("CI" or the "Company") today announced that it has successfully priced a private offering (the "Offering") of EUR1.10 billion aggregate principal amount of its 4.625% notes due ...

CI Financial Corp. ("CI" or the "Company") today announced that it has successfully priced a private offering (the "Offering") of EUR1.10 billion aggregate principal amount of its 4.625% notes due ...

Warner Bros. Discovery has told its shareholders they should reject Paramount Skydance's $108.4 billion hostile takeover bid ...

The New York State Gaming Commission voted Monday afternoon to approve three downstate casinos in New York City, granting the ...

Summary of Steps Taken to Maintain Listing Compliance SAN DIEGO, CA, Dec. 17, 2025 (GLOBE NEWSWIRE) -- RYVYL Inc. (NASDAQ: RVYL) ("RYVYL" or the "Company") today announced that stockholders approved ...